PPARG and bladder transitional cell carcinoma: In our previous study, simvastatin treatment of BLCA cells resulted in a decrease in intracellular cholesterol content and inhibition of cell proliferation, invasion and migration, which may be caused by PPARγ signaling pathway 14.